Stealth erythrocytes: Effects of polymer grafting on biophysical, biological and immunological parameters;Emazie "invisibili": Effetti dell'incorporazione di un polimero sui parametri biofisici, biologici e immunologici eritrocitari

Blood Transfusion

Volumn 1, Issue 3, 2003, Pages 244-265

  Scott, Mark D ^a   Bradley, Amanda J ^a   Murad, Kari L ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b College of St Rose ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1242311576     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. NIH Consensus Conference. Perioperative red cell transfusion. JAMA 1988; 260: 2700-3.
2. Sazama K. Reports of 355 transfusion-associated deaths: 1976-1985. Transfusion 1990; 30: 583-90.
3. Snyder EL. Transfusion reactions. In: Hoffman R, Benz Jr EJ, Shattil SJ et al., editors. Hematology: Basic Principles and Practice, New York, NY, Churchill Livingstone, 1991 pp. 1644-51.
4. Institute of Medicine Report. HIV and the blood supply. An analysis of crisis decision making. Washington, DC, National Academy Press 1996.
5. Larison PT, Cook LO. Adverse effects of blood transfusion. In: Harmening D, editor. Modern Blood Banking & Transplantation Practices, 3rd edition, Philadelphia, PA, FA Davis Co, 1994, pp.351-74.
6. Martin S. Fundamentals of immunology for blood bankers. In: Harmeming D, editor. Modern Blood Banking & Transplantation Practices, 3rd edition, Philadelphia, PA, FA Davis Co, 1994, p. 55.
7. Skov F, Hughes-Jones NC. Observations on the number of available C antigen sites on red cells. Vox Sang 1977; 33: 170-4.
8. Reid ME, Lomas-Francis C. The Blood Group Antigen Facts Book. San Diego, Ca, Academic Press, 1997.
9. Mourant AE, Kopec AC, Domaniewski-Sobczak K. Blood Groups and Disease. London: Oxford University Press, 1978.
10. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. New Eng J Med 1990; 322: 1617-21.
11. Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched with minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987; 27: 94-8.
12. Economidou J, Constantoulakis M, Augoustaki O, Adinolfi M. Frequency of antibodies to various antigenic determinants in polytransfused patients with homozygous thalassemia in Greece. Vox Sang 1971; 20: 252-8.
13. Moore SB, Taswell HF, Pineda AA, Sonnenberg CL. Delayed hemolytic transfusion reactions: evidence of the need for an improved pretransfusion compatibility test. Am J Clin Pathol 1980; 74: 94-7.
14. Sirchia G, Zanella A, Parravicini A, et al. Red cell alloantibodies in thalassemia major: results of an Italian cooperative study. Transfusion 1985; 25: 110-2.
15. Kennedy MS, Julius C. Transfusion therapy. In: Harmening D, editor. Modern Blood Banking & Transplantation Practices, 3rd edition, Philadelphia, PA, FA Davis Co, 1994, pp.316-33.
16. Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001; 41: 1086-92.
17. Zupanska B. Clinical application of functional assays for assessing the red cell antibody activity. Transfus Sci 1993; 14: 371-81.
18. Murad KL, Koumpouras F, Talbot M, et al. Molecular camouflage of antigenic determinants on intact mammalian cells: possible applications to transfusion medicine. Blood 1996; 88 (Suppl 1), 1765 (444A).
19. Scott MD, Murad KL, Eaton JW. The other blood substitute: antigenically inert erythrocytes. In: Winslow RM, Vandegriff KD, Intaglietta M, editors, Advances in Blood Substitutes:Industrial Opportunities and Medical Challenges. Boston MA, Birkhäuser, pp. 133-50.
20. Scott MD, Murad KL, Koumpouras F, et al. Chemical camouflage of antigenic determinants: "stealth" erythrocytes. Proc Nat Acad Sci USA 1997; 94, 7566-71.
21. Scott MD, Murad KL. Cellular camouflage: fooling the immune system with polymers. Curr Pharm Des 1998; 4, 423-38.
22. Murad KL, Mahany KL, Kuypers FA, et al. Structural and functional consequences of antigenic modulation of red cells with methoxypoly(ethylene glycol). Blood 1999; 93: 2121-7.
23. Murad KL, Gosselin EJ, Eaton JW, Scott MD Stealth cells: prevention of MHC Class II mediated T cell activation by cell surface modification. Blood 1999; 94: 2135-41.
24. Scott MD, Bradley AJ, Murad KL. Camouflaged red cells: low technology bioengineering for transfusion medicine? Transf Med Rev 2000; 14: 53-63.
25. Chen AM, Scott MD. Current and future applications of immunologic attenuation via PEGylation of cells and tissues. BioDrugs 2001; 15: 833-47.
26. Bradley AJ, Test TT, Murad KL, et al. Complement interactions with methoxypoly(ethylene glycol)-modified human erythrocytes. Transfusion 2001, 41: 1225-33.
27. Bradley AJ, Murad KL, Regan KL, Scott MD. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matter. Biochim Biophys Acta 2002; 1561: 147-58.
28. Chen AM, Scott MD. Immunocamouflage: prevention of transfusion-induced graft-versus-host disease via polymer grafting of donor cells. J Biomed Mater Res, in press.
29. Harris JM. Introduction to biotechnical and biomedical applications of poly(ethylene glycol). In: Harris JM, editor. Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications. New York, NY, Plenum Press 1992, pp.1-14.
30. Ahkong QF, Fisher D, Tampion W, Lucy JA. Mechanisms of cell fusion. Nature 1975, 253:194-5.
31. Drumheller PD, Hubbel JA. Densely crosslinked polymer networks of poly(ethylene glycol) in trimethylolpropane triacrylate for cell-adhesion- resistant surfaces. J Biomed Mater Res 1995; 29: 207-15.
32. Mori Y, Nagaoka S, Takiuchi H, et al. A new antithrombogenic material with polyethyleneoxide chains. Trans. Am. Soc. Artif. Internal Organs 1982; 28: 459-63.
33. Abuchowski A, van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of poly(ethylene glycol). J Biol Chem 1977; 252: 3578-81.
34. Abuchowski A, McCoy JR, Palczuk NC, et al. Effect of covalent attachment of poly(ethylene glycol) on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 1977, 252: 3582-6.
35. Jackson C-J, Charlton JL, Kuzminski K, et al. Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxypoly(ethylene glycol) using cyanuric chloride as the coupling agent. Anal Biochem 1987; 165: 114-27.
36. Zalipsky S, Brandeis E, Newman MS, Woodle MC. Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine. FEBS Lett 1994; 353: 71-4.
37. Senior J, Delgado C, Fisher D, et al. Influence of surface hydrophilicity of liposomes on their interaction with plasma and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1991; 1062: 77-82.
38. Maruyama K, Yuda T, Okamoto A, et al. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholin and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta 1992; 1128: 44-9.
39. Jeong ST, Byun SM. Decreased agglutinability of methoxy-polyethylene glycol attached red blood cells: significance as a blood substitute. Artif Cells Blood Substit Immobil Biotechnol 1996; 24: 503-11.
40. Neu B, Armstrong JK, Fisher TC, et al. Electrophoretic mobility of human red blood cells coated with poly(ethylene glycol). Biorheology 2001; 38: 389-403.
41. Neu B, Armstrong JK, Fisher TC, Meiselman HJ. Surface characterization of poly(ethylene glycol) coated human red blood cells by particle electrophoresis. Biorheology 2003; 40: 477-87.
42. Hortin GL, Lok HT, Huang ST. Progress toward preparation of universal donor red cells. Artif Cells Blood Substit Immobil Biotechnol 1997; 25: 487-91.
43. Johansson G. Affinity partitioning in PEG-containing two-phase systems. In: Harris JM editor. Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications, New York, NY, Plenum Press, pp 73-84.